DURHAM, N.C.--(BUSINESS WIRE)--Expression Analysis (EA) today announced a jointly sponsored research grant for up to eight American Cancer Society Grantees to investigate and draw parallels between specific cancers and recurring mutations in specific kinases, using targeted genome sequencing. Each grantee will provide up to 12 human samples (six disease, six control) to EA for enrichment using Agilent Technologies’ SureSelect Human Kinome Kit. EA will perform the sequencing of the kinome of each sample at no cost, using Illumina’s Genome Analyzeriix technology, reagents and flow cells. EA will then provide analysis of sequence data along with final reports and raw sequence data.
